
Reconstructive Surgery India
Founded in 2012 and headquartered in Telangana, India.
Founded in 2012 and headquartered in Telangana, India.
Hyderabad, Telangana, India
+91-XXXXXXXXXX
U85100TG2012NPL080017
080017
Private Not For Profit Company
29 Mar 2012
07 Jul 2023
31 Mar 2023
Unlisted
Roc Hyderabad
Name | Designation | Appointment Date | Status |
---|---|---|---|
Geeta Vora ![]() | Director | 14-Aug-2014 | Current |
Deeksha Gehlot ![]() | Director | 15-Dec-2018 | Current |
Sujata Mehta ![]() | Director | 07-May-2015 | Current |
Reconstructive Surgery India, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
In 2017, Reconstructive Surgery India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Reconstructive Surgery India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Reconstructive Surgery India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Reconstructive Surgery India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Reconstructive Surgery India last Annual general meeting of members was held on 07 Jul 2023 as per latest MCA records.
Reconstructive Surgery India has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.
Deeksha Gehlot was appointed as a Director was appointed as a Director on 15 Dec 2018 & has been associated with this company since 6 years 3 months .
Sujata Mehta was appointed as a Director was appointed as a Director on 07 May 2015 & has been associated with this company since 9 years 10 months .
Geeta Vora was appointed as a Director was appointed as a Director on 14 Aug 2014 & has been associated with this company since 10 years 7 months .
Reconstructive Surgery India was registered on 29 Mar 2012 with Roc Hyderabad & aged 13 years 2 days as per MCA records.
Reconstructive Surgery India was incorporated on 29 Mar 2012.
The authorized share capital of Reconstructive Surgery India is ₹ 0.10 M and paid-up capital is ₹ 0.00.
Currently 3 directors are associated with Reconstructive Surgery India.
As per Ministry of Corporate Affairs (Mca), the registered address of Reconstructive Surgery India is Plt Nos.188 * 189 Rr Towers West Block 5Th Floor, Kavuri Hills Phase -I Madhapur, Hyderabad, Telangana, India, 500081.
The corporate identification number (CIN) of Reconstructive Surgery India is U85100TG2012NPL080017 and the company number is 080017 as per Ministry of Corporate Affairs (MCA).
The most recent Balance Sheet for Reconstructive Surgery India was filed with the ROC on 31 Mar 2023.
MG
AJ